Skip to content

A Behavioral Intervention to Decrease Vomiting and Improve Weight Loss in Post-Operative Laparoscopic Adjustable Gastric Banding (LAGB) Patients

Status
Suspended
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01860053
Enrollment
5
Registered
2013-05-22
Start date
2009-05-31
Completion date
Unknown
Last updated
2013-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery Complications

Brief summary

The purpose of this study is to reduce problematic vomiting and associated gastrointestinal symptoms in post-operative LAGB patients. We hypothesize that our behavioral intervention will yield greater reductions in vomiting and associated symptoms compared to our control condition.

Interventions

BEHAVIORALbehavioral intervention

This intervention targets eating behavior to reduce vomiting and associated complications in post-operative LAGB patients.

Sponsors

The Miriam Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Age between 18 and 70 years. 2. Received LAGB surgery with either a standard Lap-Band or a standard Realize Band. 3. Report vomiting at least 3x/week. 4. Agree to allow researchers to communicate with their surgeon regarding their care. 5. Fulfilled all hospital surgery criteria.

Exclusion criteria

1. Report a condition that in the judgment of the Principal Investigator would render them potentially unlikely to follow the protocol (e.g., major illness, plans to move out of the area, substance abuse or other significant psychiatric problems, organic brain disease). 2. Report planning to become pregnant during the time frame of the investigation. 3. Report a history of upper gastrointestinal dismotility.

Design outcomes

Primary

MeasureTime frame
change in frequency of self-reported vomiting (number of vomiting episodes each week) measured via structured interviewbaseline to week 6

Secondary

MeasureTime frame
change in gastrointestinal symptom severity - questionnaire measures severity of various GI symptoms over the previous week and items are summed yielding an overall GI severity indexbaseline to week 6

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026